海角破解版

EasySep? Direct Human CTC Enrichment Kit

Immunomagnetic negative selection of untouched human circulating tumor cells (CTCs) directly from whole blood

New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more

EasySep? Direct Human CTC Enrichment Kit

Immunomagnetic negative selection of untouched human circulating tumor cells (CTCs) directly from whole blood

Catalog #
(Select a product)
Immunomagnetic negative selection of untouched human circulating tumor cells (CTCs) directly from whole blood
Request Pricing

Product Advantages


  • > 99.9% RBC depletion without the need for density gradient centrifugation, sedimentation, or lysis

  • Up to 3 log depletion of normal hematopoietic cells

  • Fast, easy-to-use and column-free

  • Isolated cells are untouched

What's Included

  • EasySep? Direct Human CTC Enrichment Kit (Catalog #19657)
    • EasySep? Direct Human CTC Enrichment Cocktail, 2 x 2.5 mL
    • EasySep? Direct RapidSpheres?, 4 x 2.5 mL

Overview

Easily and efficiently isolate highly purified human circulating tumor cells (CTCs) directly from human whole blood samples by immunomagnetic negative selection, with the EasySep? Direct Human CTC Enrichment Kit. Widely used in published research for more than 20 years, EasySep? combines the specificity of monoclonal antibodies with the simplicity of a column-free magnetic system.

In this EasySep? negative selection procedure, unwanted cells are labeled with antibody complexes and magnetic particles called EasySep? Direct RapidSpheres?. Unwanted cells expressing the following markers are targeted for removal: CD2, CD14, CD16, CD19, CD45, CD61, and CD66b. The magnetically labeled cells are then separated from the untouched desired CTCs by using an EasySep? magnet and simply pouring or pipetting the desired cells into a new tube. Following magnetic cell isolation, the desired CTCs are ready for downstream applications such as flow cytometry, culture, or DNA/RNA extraction.

Learn more about how immunomagnetic EasySep? technology works. Explore additional products optimized for your workflow, including those for cell characterization, cryopreservation, and more.

Magnet Compatibility
? EasySep? Magnet (Catalog #18000)
? “The Big Easy” EasySep? Magnet (Catalog #18001)
? Easy 50 EasySep? Magnet (Catalog #18002)
? EasyEights? EasySep? Magnet (Catalog #18103)
Subtype
Cell Isolation Kits
Cell Type
Cancer Cells and Cell Lines
Species
Human
Sample Source
Whole Blood
Selection Method
Negative
Application
Cell Isolation
Brand
EasySep
Area of Interest
Cancer, Immunology

Data Figures

CAMA cells were seeded into whole blood at a starting frequency of 0.98%. The CAMA cell (EpCAM+) content of the enriched fraction is 92.02% with a 3.8 log depletion of CD45+ cells

Figure 1. Typical EasySep? Direct Human CTC Enrichment Profile

Starting with human whole blood from healthy donors, spiked with approximately 1% of CAMA cells (epithelial tumor cell line), the typical CTC (epithelial cell+) content of non-lysed final enriched fraction is 79 ± 16 % (using the silver “Big Easy” EasySep? Magnet; gated on DRAQ5? for nucleated cells). Typically the log depletion of targeted CD45+ cells is 2.8 to 3.2. In the above example, CAMA cells were seeded into whole blood at a starting frequency of 0.98%. The CAMA cell (epithelial cell+) content of the enriched fraction is 92.02% with a 3.8 log depletion of CD45+ cells.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
19657
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19657
Lot #
All
Language
English
Document Type
Product Name
Catalog #
19657
Lot #
All
Language
English

Resources and Publications

Frequently Asked Questions

Can EasySep™ be used for either positive or negative selection?

Yes. The EasySep™ kits use either a negative selection approach by targeting and removing unwanted cells or a positive selection approach targeting desired cells. Depletion kits are also available for the removal of cells with a specific undesired marker (e.g. GlyA).

How does the separation work?

Magnetic particles are crosslinked to cells using Tetrameric Antibody Complexes (TAC). When placed in the EasySep™ Magnet, labeled cells migrate to the wall of the tube. The unlabeled cells are then poured off into a separate fraction.

Which columns do I use?

The EasySep™ procedure is column-free. That's right - no columns!

How can I analyze the purity of my enriched sample?

The Product Information Sheet provided with each EasySep™ kit contains detailed staining information.

Can EasySep™ separations be automated?

Yes. RoboSep™, the fully automated cell separator, automates all EasySep™ labeling and cell separation steps.

Can EasySep™ be used to isolate rare cells?

Yes. We recommend a cell concentration of 2x108 cells/mL and a minimum working volume of 100 µL. Samples containing 2x107 cells or fewer should be suspended in 100 µL of buffer.

Are the EasySep™ magnetic particles FACS-compatible?

Yes, the EasySep™ particles are flow cytometry-compatible, as they are very uniform in size and about 5000X smaller than other commercially available magnetic beads used with column-free systems.

Can the EasySep™ magnetic particles be removed after enrichment?

No, but due to the small size of these particles, they will not interfere with downstream applications.

Can I alter the separation time in the magnet?

Yes; however, this may impact the kit's performance. The provided EasySep™ protocols have already been optimized to balance purity, recovery and time spent on the isolation.

For positive selection, can I perform more than 3 separations to increase purity?

Yes, the purity of targeted cells will increase with additional rounds of separations; however, cell recovery will decrease.

How does the binding of the EasySep™ magnetic particle affect the cells? is the function of positively selected cells altered by the bound particles?

Hundreds of publications have used cells selected with EasySep™ positive selection kits for functional studies. Our in-house experiments also confirm that selected cells are not functionally altered by the EasySep™ magnetic particles.

If particle binding is a key concern, we offer two options for negative selection. The EasySep™ negative selection kits can isolate untouched cells with comparable purities, while RosetteSep™ can isolate untouched cells directly from whole blood without using particles or magnets.

Publications (2)

Facile, rapid and efficient isolation of circulating tumor cells using aptamer-targeted magnetic nanoparticles integrated with a microfluidic device. A. A. Kajani et al. RSC advances 2022 nov

Abstract

Facile and sensitive detection and isolation of circulating tumor cells (CTCs) was achieved using the aptamer-targeted magnetic nanoparticles (Apt-MNPs) in conjugation with a microfluidic device. Apt-MNPs were developed by the covalent attachment of anti-MUC1 aptamer to the silica-coated magnetic nanoparticles via the glutaraldehyde linkers. Apt-MNPs displayed high stability and functionality after 6 months of storage at 4 °C. The specific microfluidic device consisting of mixing, sorting and separation modules was fabricated through conventional photo- and soft-lithography by using polydimethylsiloxane. The capture efficiency of Apt-MNPs was first studied in vitro on MCF-7 and MDA-MB-231 cancer cell lines in the bulk and microfluidic platforms. The cell capture yields of more than 91% were obtained at the optimum condition after 60 minutes of exposure to 50 $\mu$g mL-1 Apt-MNPs with 10 to 106 cancer cells in different media. CTCs were also isolated efficiently from the blood samples of breast cancer patients and successfully propagated in vitro. The isolated CTCs were further characterized using immunofluorescence staining. The overall results indicated the high potential of the present method for the detection and capture of CTCs.
Label-free detection of rare circulating tumor cells by image analysis and machine learning. S. Wang et al. Scientific reports 2020

Abstract

Detection and characterization of rare circulating tumor cells (CTCs) in patients' blood is important for the diagnosis and monitoring of cancer. The traditional way of counting CTCs via fluorescent images requires a series of tedious experimental procedures and often impacts the viability of cells. Here we present a method for label-free detection of CTCs from patient blood samples, by taking advantage of data analysis of bright field microscopy images. The approach uses the convolutional neural network, a powerful image classification and machine learning algorithm to perform label-free classification of cells detected in microscopic images of patient blood samples containing white blood cells and CTCs. It requires minimal data pre-processing and has an easy experimental setup. Through our experiments, we show that our method can achieve high accuracy on the identification of rare CTCs without the need for advanced devices or expert users, thus providing a faster and simpler way for counting and identifying CTCs. With more data becoming available in the future, the machine learning model can be further improved and can serve as an accurate and easy-to-use tool for CTC analysis.
New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more